v3.10.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets    
Cash and cash equivalents $ 125,573 $ 883,962
Accounts receivable 1,709,915 1,877,743
Grants receivable 819,615 804,152
Inventory 2,420,988 2,206,570
Other current assets 106,614 157,621
Total Current Assets 5,182,705 5,930,048
Property, plant and equipment, net 3,449,467 3,569,832
Investments 112,072 112,072
Intangible assets, net 9,833,647 10,739,492
Total Assets 18,577,891 20,351,444
Current Liabilities    
Accounts payable 2,822,693 2,575,399
Accrued liabilities 1,558,501 503,751
Current portion of long-term debt, net of original discount 1,673,667 866,479
Advance grant payments 568,844 935,817
Deferred liabilities 401,478 174,230
Accrued interest 86,088 78,049
Total Current Liabilities 7,111,271 5,133,725
Long-term debt, net of original discount 2,327,666 3,348,730
Total Liabilities 9,438,937 8,482,455
Stockholders' Equity    
Common stock - 75,000,000 shares authorized, $.001 par value; 1,965,646 and 1,970,915 issued and outstanding at September 30, 2018 and December 31, 2017, respectively 1,966 1,971
Additional paid-in capital 15,838,654 15,523,606
Equity instruments to be issued 65,839 65,839
Accumulated deficit (6,810,662) (3,743,438)
Accumulated other comprehensive income 43,157 21,011
Total Stockholders' Equity 9,138,954 11,868,989
Total Liabilities and Stockholders' Equity $ 18,577,891 $ 20,351,444

Source